Guanidinoacetate ( GAA ) is a potent GABA A receptor GABA mimetic: Implications for neurological disease pathology
Journal of Neurochemistry · 2023-05 · 165 (3) · 445-454
DOI: 10.1111/jnc.15774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 16.02.2023. Verfasst von Pratap Meera und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Receptors, GABA-A, Creatine. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Impairment of excretion and enzymatic processing of nitrogen, for example, because of liver or kidney failure, or with urea cycle and creatine synthesis enzyme defects, surprisingly leads to primarily neurologic symptoms, yet the exact mechanisms remain largely mysterious. In guanidinoacetate N‐methyltransferase (GAMT) deficiency, the guanidino compound guanidinoacetate (GAA) increases dramatically, including in the cerebrospinal fluid (CSF), and has been implicated in mediating the neurological symptoms in GAMT‐deficient patients. GAA is synthesized by arginine–glycine amidinotransferase (AGAT), a promiscuous enzyme that not only transfers the amidino group from arginine to glycine, but also to primary amines in, for example, GABA and taurine to generate γ‐guanidinobutyric acid (γ‐GBA) and guanidinoethanesulfonic acid (GES), respectively. We show that GAA, γ‐GBA, and GES share structural similarities with GABA, evoke GABA A receptor (GABA A R) mediated currents (whereas creatine [methylated GAA] and arginine failed to evoke discernible currents) in cerebellar granule cells in mouse brain slices and displace the high‐affinity GABA‐site radioligand [ 3 H]muscimol in total brain homogenate GABA A Rs. While γ‐GBA and GES are GABA agonists and displace [ 3 H]muscimol (EC 50 /IC 50 between 10 and 40 μM), GAA stands out as particularly potent in both activating GABA A Rs (EC 50 ~6 μM) and also displacing the GABA A R ligand [ 3 H]muscimol (IC 50 ~3 μM) at pathophysiologically relevant concentrations. These findings stress the role of substantially elevated GAA as a primary neurotoxic agent in GAMT deficiency and we discuss the potential role of GAA in arginase (and creatine transporter) deficiency which show a much more modest increase in GAA concentrations yet share the unique hyperexcitability neuropathology with GAMT deficiency. We conclude that orthosteric activation of GABA A Rs by GAA, and potentially other GABA A R mimetic guanidino compounds (GCs) like γ‐GBA and GES, interferes with normal inhibitory GABAergic neurotransmission which could mediate, and contribute to, neurotoxicity. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, University of California, Los Angeles, California, USA.
- Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
- Departments of Surgery, University of California, Los Angeles, California, USA.
- Molecular & Medical Pharmacology, University of California, Los Angeles, California, USA.
- Intellectual and Developmental Disabilities Research Center, University of California, Los Angeles, California, USA.
- Semel Institute for Neuroscience, University of California, Los Angeles, California, USA.
ORCID-Profile: Pratap Meera, Mikko Uusi-Oukari, Martin Wallner, Gerald S Lipshutz
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Meera, P., Uusi-Oukari, M., Wallner, M., & Lipshutz, G. S. (2023). Guanidinoacetate ( GAA ) is a potent GABA A receptor GABA mimetic: Implications for neurological disease pathology. Journal of Neurochemistry, 165(3), 445-454. https://doi.org/10.1111/jnc.15774
Vancouver
Meera P, Uusi-Oukari M, Wallner M, Lipshutz GS. Guanidinoacetate ( GAA ) is a potent GABA A receptor GABA mimetic: Implications for neurological disease pathology. Journal of Neurochemistry. 2023;165(3):445-454. doi:10.1111/jnc.15774
BibTeX
@article{Meera2023,
author = {Meera, Pratap and Uusi-Oukari, Mikko and Wallner, Martin and Lipshutz, Gerald S},
title = {Guanidinoacetate ( GAA ) is a potent GABA A receptor GABA mimetic: Implications for neurological disease pathology},
journal = {Journal of Neurochemistry},
year = {2023},
volume = {165},
number = {3},
pages = {445--454},
doi = {10.1111/jnc.15774}
}
EUVIMED